“Early and Sustained Treatment Satisfaction Observed in Patients With Moderate to Severe Psoriasis Treated With Ixekizumab: Results From Second Interim Analysis of the Real-World Psoriasis in Special Areas (PSoSA) Study”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 1, Jan. 2025, p. s509, https://doi.org/10.25251/skin.9.supp.509.